Your first 90 days
Your first 90 days on Tryngolza for familial chylomicronemia syndrome (FCS)
What happens before the first fill, the days that matter, the label's rules and who to call, from the label, the drugmaker's own program and one insurer's written rules.
Tryngolza has no safety program forms and no dose build-up for FCS. The first dose waits on a prescription sent to one of 4 network pharmacies, an insurance approval and a call or text from that pharmacy. After that comes one autoinjector a month, alongside the low-fat diet the label keeps in place. This page lays out those weeks from the FDA label, Ionis's own Tryngolza pages and one insurer's written rules.
What has to happen before the first bottle ships
Tryngolza has no REMS, so the first dose waits on a network pharmacy, a prior authorization, a pharmacy call and injection training. These are the 10 things in the way, in order.
A prescription sent to a network pharmacy
Ionis says Tryngolza comes through a select pharmacy network of Accredo, BlinkRx, CVS Specialty and Optum Specialty Pharmacy.
- Your doctor sends the prescription electronically or faxes the Tryngolza Start Form to one of them.
- Ionis notes that some insurance plans require a specific pharmacy.HCP access page
A call or text from the pharmacy
Ionis says the pharmacy calls or texts to review your coverage, your out-of-pocket costs and financial assistance options.
- Its page says answering those calls and texts helps you avoid delays in getting Tryngolza.Getting started page
The insurance approval
Ionis says your doctor may need to send information to your plan to get Tryngolza approved.
- That can include recent lipid panels, your symptoms, any pancreatitis attacks and hospital visits, and your current treatment plan.Getting started page
What one plan asks for
Cigna asks for a fasting triglyceride level of 880mg/dL or higher from before treatment, with documentation.
- It accepts a gene test, a clinical score after an inconclusive gene test, or a clinical diagnosis that meets its list.
- It also asks for a low-fat diet and a specialist prescriber.Cigna policy
Free medicine while coverage is decided
The Start Form describes Quick Start, which provides free Tryngolza during the insurance approval process for insured patients who are eligible.
- It begins once all the prior authorization information is received.
- The form says it is not for people without insurance or after an insurer's final coverage decision.Start Form
A liver test the label says to consider
The label tells prescribers to consider liver enzyme testing before Tryngolza is started.
- The Patient Information says your healthcare provider may do liver tests before you start taking it.FDA label
Injection training
The Patient Information says your healthcare provider will show you or your caregiver how to inject the first time.
- The Instructions for Use say to read them before the first dose and each time you get a refill.FDA label
Signing up for Ionis Every Step
You can enroll at TRYNGOLZA.com/Enroll, sign the Tryngolza Start Form in your doctor's office, or call 1-844-789-8744 and select option 2.
- Ionis says its consent is required for all Ionis Every Step coverage and affordability programs.Ionis Every Step brochure
The low-fat diet stays in place
The label approves Tryngolza as an addition to diet, and it tells people with FCS to eat 20g of fat or less a day.
- In the FCS trial, everyone followed that diet for at least 4 weeks before the first dose.FDA label
A medicine list for your care team
The Patient Information asks you to tell your provider about every prescription and over-the-counter medicine, vitamin and herbal supplement.
- It suggests keeping a list to show your provider and pharmacist when you get a new medicine.FDA label
The days that matter
Counted from the first dose, with one autoinjector a month, a delivery before each dose and the checks the label describes. Type your first-dose date and the tiles become real dates you can add to your calendar.
The tiles below count days from a first dose. Enter the date of yours, or the date you expect, and each tile becomes a real date on your calendar.
The date stays on your device. It is not sent to Trial Friend or anyone else. The calendar file works with Apple, Google and Outlook calendars.Prescription sent to a network pharmacy
Your doctor sends the prescription electronically, or faxes the Start Form, to one of the 4 pharmacies in the Tryngolza network.
- No source says how long the steps before the first dose take.
The pharmacy calls or texts
The pharmacy reviews your insurance coverage, your out-of-pocket costs and financial assistance options with you.
- Ionis suggests saving the pharmacy's number as a contact so you recognize the call.
Prior authorization, and Quick Start
The Start Form says eligible insured patients are enrolled in Quick Start once all the prior authorization information is received.
- Quick Start provides free Tryngolza during the insurance approval process.
Delivery, a Welcome Kit and training
The pharmacy confirms delivery details, then ships Tryngolza and a Welcome Kit directly to you.
- Ionis says the pharmacy also gives you injection training for your first dose.
First dose
One 80mg autoinjector, into the belly or the front of the thigh.
- The instructions say to take it out of the refrigerator 30 minutes before the shot and leave it in its carton to warm.
Next delivery, one autoinjector at a time
The Start Form writes each fill as one single-dose autoinjector, with refills.
- Ionis says the pharmacy reaches out when a refill is due, and you can also request it yourself.
ApoC-III at 1 month in the trial
Tryngolza lowers apoC-III, a protein that slows the clearing of triglycerides from the blood.
- In the FCS trial, apoC-III was 57% lower than on placebo at 1 month.
Second dose, then once a month
The Patient Information says Tryngolza should be injected 1 time each month.
- If a dose is missed, it says to take it as soon as possible, then inject 1 month from that date.
Next delivery, number 2
Second dose, number 2
Next delivery, number 3
Three months in
In the FCS trial, apoC-III was 69% lower than on placebo at 3 months.
- The trial's main triglyceride result was measured at 6 months.
- Your endocrinologist decides when your own triglyceride levels are checked again.
Second dose, number 3
The label, revision by revision
The FDA lists which sections changed in each revision of a label. These are the revisions the current Tryngolza label records, dated by the FDA, with a plain note on what each one meant for a patient. Older references and handouts can lag these by months.
Current label dated July 3, 2026, read from the FDA's label database today. FDA label
- June 2026
The FDA added a second use on June 24th, lowering triglycerides and the risk of acute pancreatitis in adults with severe hypertriglyceridemia. The same update added a 50mg dose for that use and a new warning about liver enzyme increases. The dose for FCS stayed the same, at 80mg once a month.FDA letter
- December 2024
The FDA first approved Tryngolza on December 19th, as an addition to diet to lower triglycerides in adults with FCS. The approval letter requires Ionis to finish 2 placebo-controlled trials and a 2-year extension trial that look for liver injury. It also asks Ionis to report liver toxicity cases within 15 days through the fifth year after approval.FDA letter
How the label says to take it
The parts of the prescribing information and the patient leaflet that come up in the first 3 months, in plain words.
- The dose for FCS
The label's recommended dose for adults with FCS is 80mg under the skin once a month.
- Each autoinjector holds one dose and can be used only 1 time.FDA label
- A different dose for a different condition
The same label covers severe hypertriglyceridemia, meaning triglycerides of 500mg/dL or higher, as a separate use.
- That use starts at 50mg once a month, which the prescriber may raise to 80mg.
- The label says 50mg is not an approved dose for FCS.FDA label
- The diet continues
The label says to keep a low-fat diet while using Tryngolza, with 20g of fat or less a day for people with FCS.
- The Patient Information words the limit as less than 20 grams of fat each day.FDA label
- Who gives the shot
The label says patients or caregivers are trained on preparing and giving Tryngolza before treatment starts.
- The Patient Information says it is not known if Tryngolza is safe and effective in children.FDA label
- Who should not use it
The Patient Information says not to use Tryngolza if you have had a serious allergic reaction to olezarsen or any of its ingredients.
- The ingredients are listed at the end of the Patient Information.FDA label
- Where the shot goes
Use the belly or the front of the thigh, at least 2 inches (5cm) from the belly button.
- The instructions say only a healthcare provider or caregiver may use the back of the upper arm.FDA label
- Skin to avoid
The instructions say not to inject into skin that is bruised, tender, red or hard, or into scars or damaged skin.FDA label
- If a dose is missed
The Patient Information says to take a missed dose as soon as possible.
- The next dose is then due 1 month from the date of that dose, which puts you back on a monthly schedule.FDA label
- Storage
Keep the autoinjector in the refrigerator at 36°F to 46°F (2°C to 8°C), in its original carton.
- The label says not to expose it to heat and to protect it from light.FDA label
- Out of the refrigerator
Tryngolza can stay at room temperature, 59°F to 86°F (15°C to 30°C), in the original carton for up to 6 weeks.
- The Patient Information says to throw it away if it has been at room temperature longer than 6 weeks.
- It also says not to let Tryngolza reach temperatures above 86°F (30°C).FDA label
- Warming and checking before the shot
Let the autoinjector warm in its carton for 30 minutes, without a microwave or hot water.
- The medicine should look clear and colorless to yellow, and air bubbles are normal.
- The instructions say not to use one that is cloudy, discolored, expired or damaged.FDA label
- Giving the full dose
The instructions say to push firmly, listen for a click and hold the autoinjector against the skin for 10 seconds.
- The orange plunger rod should fill the whole viewing window.
- If it does not, the instructions say to contact your healthcare provider.FDA label
- Used autoinjectors
Put each used autoinjector in a sharps container right away, and never reuse it.
- The instructions describe a heavy-duty plastic household container with a tight lid if you do not have an FDA-cleared one.FDA label
- Liver tests
The label says Tryngolza can raise liver enzymes and liver fat, more often at 80mg than at 50mg.
- It tells prescribers to consider liver enzyme testing before starting and when clinically needed afterward.
- It also names testing before a dose increase, a step the label describes only for severe hypertriglyceridemia.
- The prescriber decides what happens if the results stay high.FDA label
- Kidney and liver problems
The label says no dose change is needed with mild or moderate kidney or liver impairment.
- Tryngolza has not been studied in people with severe kidney impairment, end-stage kidney disease or severe liver impairment.FDA label
- Blood test changes seen in the FCS trial
Average fasting blood sugar and HbA1c rose over time on Tryngolza, by up to 17mg/dL and less than 0.2 percentage points.
- LDL cholesterol also rose, from an average of 23mg/dL at the start.
- The label says it stayed under 70mg/dL for 74% of people on Tryngolza.FDA label
- Pregnancy and breastfeeding
There are no data on Tryngolza in pregnant women, and it is not known whether it passes into breast milk.
- The label notes that triglycerides rise late in pregnancy, which raises the risk of pancreatitis in people with FCS.
- The Patient Information asks you to tell your provider if you become pregnant.FDA label
What the label says to act on
The symptoms the label singles out, and what it tells patients and prescribers to do about each. If any of these happen, the label's instruction is the one to follow, with your care team.
Signs of a serious allergic reaction
Redness of the skin, red itchy bumps (hives), swelling of the face, chills or trouble breathing.
- The Patient Information says to stop Tryngolza and call your healthcare provider or get emergency help right away.
- In the FCS trial, 7% of people on Tryngolza stopped because of side effects, most often allergic reactions.FDA label
Signs of liver problems
Feeling tired or weak, loss of appetite, discomfort in the upper right stomach area, dark colored urine, or yellowing of the skin and eyes.
- The Patient Information says to tell your healthcare provider right away if you have these symptoms.FDA label
Reactions where the shot went in
Redness, itching, rash or pain at the injection site was the most common side effect in people with FCS.
- It occurred in 19% of people on Tryngolza against 9% on placebo.FDA label
Lower platelets and joint pain
A lower platelet count occurred in 12% of people on Tryngolza against 4% on placebo.
- Joint pain or stiffness occurred in 9% against none on placebo.
- The label reports no major bleeding events linked to low platelet counts.FDA label
Higher blood sugar
Among people with FCS who did not have diabetes at the start, 52% on Tryngolza had signs of high blood sugar, against 35% on placebo.
- The label counted side effect reports, new diabetes medicines and lab values.FDA label
Pancreatitis in the trial
Over 12 months, 1 person (5%) on Tryngolza 80mg had acute pancreatitis, against 7 people (30%) on placebo.
- The label calls this difference numerical, and all 8 had a history of pancreatitis.
- For FCS, the label approves Tryngolza to lower triglycerides, used along with diet.FDA label
A dose that may not have gone in
If the orange plunger rod does not fill the viewing window, you may not have received the full dose.
- The instructions say to contact your healthcare provider if this happens.FDA label
Why the pharmacy or the insurer says no, and what fixes it
Most first-fill delays are one of these. Knowing which one tells you who to call.
- Prior authorization pending or deniedCigna asks for a fasting triglyceride level of 880mg/dL or higher at baseline, with documentation. Baseline means the level before any triglyceride-lowering medicine was started. It also wants a patient aged 18 or older and a low-fat diet alongside Tryngolza. Cigna says documentation may include chart notes and laboratory tests.Cigna policy
- The plan wants proof of the FCS diagnosisCigna accepts a gene test showing disease-causing variants in both copies of an FCS gene. It also accepts an inconclusive gene test with a Moulin score of 10 or more or a North American FCS score of 45 or more. Its third route is a clinical diagnosis that meets every item on its list.Cigna policy
- No gene test on fileCigna's clinical route asks for pancreatitis not caused by alcohol or gallstones, or repeated hospital stays for severe unexplained belly pain. It also asks that other causes of high triglycerides are absent and that standard triglyceride medicines did not work. Other plans set their own rules for how the diagnosis is shown.Cigna policy
- The prescriber is not a specialist the plan listsCigna asks for a cardiologist, an endocrinologist, a lipidologist or a physician who focuses on disorders related to severe hypertriglyceridemia. The office names the prescriber's specialty on the prior authorization request.Cigna policy
- The first approval ran outCigna approves the first 6 months, then a year at a time once there is a response to therapy. It gives lower triglycerides or fewer pancreatitis episodes as examples of a response. The office sends the follow-up triglyceride results with the renewal request.Cigna policy
- The prescription went to a pharmacy outside the networkTryngolza is dispensed through Accredo, BlinkRx, CVS Specialty and Optum Specialty Pharmacy. Ionis says some plans require a specific one, so it is important to confirm with the plan before the prescription is sent. It says BlinkRx can pass a prescription to another network pharmacy that a plan requires.HCP access page
- The medicine has not shippedIonis says the pharmacy calls or texts to review coverage and costs and to confirm delivery details. If you are not sure which pharmacy you are using, Ionis Every Step can tell you at 1-844-789-8744, option 2.Getting started page
- An appeal after a denialIonis says the network pharmacies start prior authorization requests and provide support with appeals. Its prescriber site lists a sample Letter of Medical Necessity on its Resources page. Ionis also lists the prescribing information and the FDA approval letter as helpful materials to send.HCP access page
- A copay you cannot payWith commercial insurance, Ionis says you may pay as little as $0 for each fill through the Ionis Every Step Copay Program. People who use Medicare, Medicaid, TRICARE, Department of Defense, Veterans Administration or other government programs for medicine costs are excluded.Ionis Every Step
- No insurance, or a plan that does not cover TryngolzaIonis says you may be eligible to get Tryngolza at no cost through the Ionis Every Step Patient Assistance Program. Staying eligible depends on reviews of insurance and financial information, including a yearly reapplication.Ionis Every Step brochure
- A gap in insurance coverageIonis says its Bridge program may give a short-term supply at no cost during a temporary gap in commercial insurance. You have to be eligible, and program terms and limits apply.Ionis Every Step brochure
Cigna prior authorization policy, September 1, 2026
- Age 18 or older
- A fasting triglyceride level of 880mg/dL or higher at baseline, before any triglyceride-lowering medicine, with documentation
- A gene test showing disease-causing variants in both copies of at least one FCS gene, such as LPL, GPIHBP1, APOA5, APOC2 or LMF1, with documentation
- Or an inconclusive gene test plus a Moulin FCS score of 10 or more, or a North American FCS score of 45 or more
- Or a clinical diagnosis, which needs pancreatitis not caused by alcohol or gallstones, or repeated hospital stays for severe unexplained belly pain
- For that clinical diagnosis, also no secondary cause such as obesity or uncontrolled diabetes, and no response to standard triglyceride medicines
- Used together with a low-fat diet
- Prescribed by a cardiologist, an endocrinologist, a lipidologist or a physician who focuses on disorders related to severe hypertriglyceridemia
Approval length. The first approval lasts 6 months, and renewal is a year at a time after a response, such as lower triglycerides or fewer pancreatitis episodes.
This version was reviewed on July 23, 2026, after the June 2026 label, and took effect September 1, 2026. It added severe hypertriglyceridemia as a second route with its own criteria and shortened the first FCS approval from 1 year to 6 months. Its reference list still cites the January 2025 prescribing information. Other plans set their own criteria, so this one is here as an example, not as a rule. Cigna policy
Who to call, and what they can do
The drugmaker's program handles most of the first-fill problems above. Charity funds and foundation help are on the help paying page.
- A copay program where a person with commercial insurance may pay as little as $0 for each fill of Tryngolza
- No copay help for anyone who uses Medicare, Medicaid, TRICARE, Department of Defense, Veterans Administration or other government programs for medicine costs
- Other financial support programs for people without insurance or whose insurance does not cover Tryngolza
- Injection training, regular check-ins and extra support if you need more help using Tryngolza
- Digital resources on how to use Tryngolza, nutrition tips and tools, and treatment goals
- Quick Start, free Tryngolza during the insurance approval process for eligible insured patients, once the prior authorization information is in Start Form
- Bridge, a short-term supply at no cost during a temporary gap in commercial insurance, for people who are eligible Ionis Every Step brochure
- A Patient Assistance Program that may provide Tryngolza at no cost when insurance does not cover it or you have none, with a yearly reapplication Ionis Every Step brochure
- Home delivery from the network pharmacy, which also contacts you when a refill is due Getting started page
Details as the drugmaker publishes them. Ionis Every Step
Five questions for the pharmacist or the support line
- Which of the 4 network pharmacies are you, and what number will your calls and texts come from?
- When will each autoinjector ship, and how do I request a refill before my next monthly dose?
- What do I do if a shipment arrives warm, or I lose track of how long one sat out of the refrigerator?
- Is my prescription written for the 80mg autoinjector, the FCS dose in the label?
- Where can I get a sharps container for used autoinjectors?
Questions people ask in the first weeks
How often is Tryngolza injected for FCS?
Once a month, at 80mg under the skin from a single-dose autoinjector, which is the label's recommended dose for adults with FCS. The prescriber decides the dose and schedule that are right for you.
Can I give Tryngolza myself?
Yes, after training, and the Patient Information says your healthcare provider shows you or your caregiver how to inject the first time. The belly or the front of the thigh can be used for the shot. Only a caregiver or healthcare provider may use the back of the upper arm.
What if I miss a dose of Tryngolza?
The Patient Information says to take the missed dose as soon as possible. The next dose is then due 1 month from the date of that dose.
Do I still need the low-fat diet on Tryngolza?
Yes, the label approves Tryngolza only as an addition to diet. It tells people with FCS to eat 20g of fat or less a day while using Tryngolza.
Do I need blood tests on Tryngolza?
The label sets no fixed schedule of blood tests for people taking Tryngolza. It tells prescribers to consider liver enzyme testing before starting and when clinically needed afterward. It also names testing before a dose increase, a step the label describes only for severe hypertriglyceridemia. The endocrinologist also decides when your triglycerides are checked during treatment.
How do I store Tryngolza?
In the refrigerator at 36°F to 46°F (2°C to 8°C), in the original carton. It can also stay at room temperature, 59°F to 86°F (15°C to 30°C), in the carton for up to 6 weeks. The Patient Information says to throw it away after that.
Is the FCS dose the same as the dose for severe hypertriglyceridemia?
No, the label gives 80mg once a month for FCS and a different starting dose for the other use. For severe hypertriglyceridemia, a separate use added in June 2026, it gives 50mg once a month, which the prescriber may raise to 80mg.
Does Medicare work with the Tryngolza copay program?
No, the copay program excludes anyone who uses Medicare, Medicaid, TRICARE, Veterans Administration or other government programs for medicine costs. Ionis says it has other financial support, including a Patient Assistance Program for people whose insurance does not cover Tryngolza.
Free email alert
Hear when the Tryngolza label changes
One email the day the FDA revises the Tryngolza label, with what changed in plain words. No trial alerts, no newsletter.
Label changes for Tryngolza only, usually a few a year and some years none. Stop anytime. We never share your email. Privacy policy
Want the whole condition instead? Follow Familial chylomicronemia syndrome (FCS) for new trials, FDA decisions and label changes for every treatment.
Sources
- DailyMed - TRYNGOLZA- olezarsen sodium injection, solution (prescribing information revised 6/2026, Patient Information and Instructions for Use revised 06/2026), Ionis Pharmaceuticals, Inc., via DailyMed and openFDA, July 3, 2026.
- Approved Risk Evaluation and Mitigation Strategies (REMS), FDA, November 13, 2026.
- Access and Support | TRYNGOLZA® (olezarsen) for FCS, Ionis Pharmaceuticals, November 13, 2026.
- Getting Started with TRYNGOLZA® | TRYNGOLZA® (olezarsen) for FCS, Ionis Pharmaceuticals, November 13, 2026.
- Ionis Every Step brochure: Let's Take This Step by Step, Together (US-OLZ-2400107 v3.0 06/2026), Ionis Pharmaceuticals, November 13, 2026.
- TRYNGOLZA Start Form (US-OLZ-2600487 v1.0 09/2026), Ionis Pharmaceuticals, November 13, 2026.
- Access and Support | TRYNGOLZA® (olezarsen), Ionis Pharmaceuticals, November 13, 2026.
- Hypertriglyceridemia - Tryngolza, Drug Coverage Policy IP0733, Cigna, September 1, 2026.
- NDA 218614/S-004 supplement approval letter, Tryngolza (olezarsen) injection, FDA, June 24, 2026.
- NDA 218614 approval letter, Tryngolza (olezarsen) injection, FDA, December 19, 2024.
This page explains what the FDA label, the drugmaker's support program and an insurer policy say. It is not medical advice and does not tell anyone to start, stop or change a medicine. Dosing, test timing and restarts after a gap are decisions for the prescribing endocrinologist. Found an error? Use the report link in the footer and it will be checked against the source.